AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Features


Laboratorians have long faced challenges in the diagnoses of sepsis. While there is yet to find a specific biomarker that can detect the deadly disease, labs across the world are racing to develop tests that can get one step closer to finding answers.
As next-generation sequencing keeps advances, gene variant information can change rapidly. This can place laboratorians in a dilemma about deciding how often to reinterpret data, and when to inform providers or patients with updated variant calls.

Ask the Expert


Bench Matters


Federal Insider


Industry Playbook


Laboratory Stewardship


In an era of rapid advances in genomic testing and technologies, laboratory test stewardship can assist laboratorians in implementing the latest technologies and taking the appropriate steps from clinical research to clinical testing.

Mini Review


Regulatory Roundup


The COVID-19 outbreak has increased the need for testing worldwide. While FDA first required laboratories and companies to receive an emergency use authorization before testing, the agency quickly loosened this requirement, which has particularly sped the development of tests in the U.S. for the deadly pandemic.

The Sample